Skip to Content

GS LHF 75 mg (Tafinlar 75 mg)

Generic Name: dabrafenib

This pill with imprint "GS LHF 75 mg" is Pink, Capsule-shape and has been identified as Tafinlar 75 mg. It is supplied by GlaxoSmithKline.

Tafinlar is used in the treatment of melanoma, metastatic and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GS LHF 75 mg

Tafinlar

Generic Name:
dabrafenib
Imprint:
GS LHF 75 mg
Strength:
75 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
National Drug Code (NDC):
00173-0847

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide